NCT06526104 2026-01-06
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
The University of Texas Health Science Center at San Antonio
Phase 2 Recruiting
Clinical Trials
8 trialsNCT04172779 2025-11-20
ECHO-B
University of Texas Southwestern Medical Center
Phase 2 Not yet recruiting
NCT06015022 2025-09-05
CATCH-B
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT05304234 2024-06-04
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
Phase 2 Recruiting
NCT02289300 2020-01-13
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
A2 Healthcare Taiwan Corporation
Phase 2 Withdrawn
NCT02256514 2019-08-30
HCC
Immunitor LLC
Phase 2 Unknown
NCT01686880 2015-07-01
TRYPHON
Jules Bordet Institute
Phase 2 Terminated
NCT01423708 2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2 Unknown